Comparative Pharmacology
Head-to-head clinical analysis: NUTRACORT versus PREDNICARBATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NUTRACORT versus PREDNICARBATE.
NUTRACORT vs PREDNICARBATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Corticosteroid receptor agonist; induces anti-inflammatory proteins and suppresses inflammatory mediators.
Prednicarbate is a corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. It binds to glucocorticoid receptors, leading to inhibition of phospholipase A2, decreased release of arachidonic acid, and reduced synthesis of prostaglandins and leukotrienes.
One capsule (200 mg) orally twice daily with meals.
Topical: apply sparingly to affected area twice daily; maximum 50 g per week.
None Documented
None Documented
Terminal half-life: 2-4 hours (mean 3 hours). Clinically, dosing every 6-8 hours maintains therapeutic levels.
Clinical Note
moderatePrednicarbate + Gatifloxacin
"The risk or severity of adverse effects can be increased when Prednicarbate is combined with Gatifloxacin."
Clinical Note
moderatePrednicarbate + Rosoxacin
"The risk or severity of adverse effects can be increased when Prednicarbate is combined with Rosoxacin."
Clinical Note
moderatePrednicarbate + Levofloxacin
"The risk or severity of adverse effects can be increased when Prednicarbate is combined with Levofloxacin."
Clinical Note
moderateTerminal elimination half-life: approximately 1-2 hours; clinical context: short half-life supports topical use with minimal systemic accumulation
Renal (primarily as glucuronide and sulfate conjugates, <10% unchanged) and fecal (biliary excretion of metabolites). Approximately 70-80% renal, 20-30% fecal.
Primarily renal (<2% unchanged) and fecal (biliary excretion of metabolites)
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid
Prednicarbate + Trovafloxacin
"The risk or severity of adverse effects can be increased when Prednicarbate is combined with Trovafloxacin."